Because there is no report of JAK1 methylation so far and the unavailability of antibodies targeting methylated JAK1, we first immunoprecipitated and collected JAK1 protein from the control and mdig-silenced MM cells and then probed the samples with an antibody that selectively recognizes methylated lysine. Here, JAK1 is linked to Miyoshi myopathy.